BACKGROUND: The goal of the present study was to determine the predictive value of beat-to-beat QT variability in heart failure patients across the continuum of left ventricular dysfunction. METHODS AND RESULTS: Beat-to-beat QT variability index (QTVI), log-transformed heart rate variance, normalized QT variance, and coherence between heart rate variability and QT variability have been measured at rest during sinus rhythm in 533 participants of the Muerte Subita en Insuficiencia Cardiaca heart failure study (mean age, 63.1±11.7; men, 70.6%; left ventricular ejection fraction >35% in 254 [48%]) and in 181 healthy participants from the Intercity Digital Electrocardiogram Alliance database. During a median of 3.7 years of follow-up, 116 patients died, 52 from sudden cardiac death (SCD). In multivariate competing risk analyses, the highest QTVI quartile was associated with cardiovascular death (subhazard ratio, 1.67 [95% CI, 1.14-2.47]; P=0.009) and, in particular, with non-SCD (subhazard ratio, 2.91 [1.69-5.01]; P<0.001). Elevated QTVI separated 97.5% of healthy individuals from subjects at risk for cardiovascular (subhazard ratio, 1.57 [1.04-2.35]; P=0.031) and non-SCD in multivariate competing risk model (subhazard ratio, 2.58 [1.13-3.78]; P=0.001). No interaction between QTVI and left ventricular ejection fraction was found. QTVI predicted neither noncardiac death (P=0.546) nor SCD (P=0.945). Decreased heart rate variability rather than increased QT variability was the reason for increased QTVI in the present study. CONCLUSIONS: Increased QTVI because of depressed heart rate variability predicts cardiovascular mortality and non-SCD but neither SCD nor extracardiac mortality in heart failure across the continuum of left ventricular dysfunction. Abnormally augmented QTVI separates 97.5% of healthy individuals from heart failure patients at risk.
BACKGROUND: The goal of the present study was to determine the predictive value of beat-to-beat QT variability in heart failurepatients across the continuum of left ventricular dysfunction. METHODS AND RESULTS: Beat-to-beat QT variability index (QTVI), log-transformed heart rate variance, normalized QT variance, and coherence between heart rate variability and QT variability have been measured at rest during sinus rhythm in 533 participants of the Muerte Subita en Insuficiencia Cardiaca heart failure study (mean age, 63.1±11.7; men, 70.6%; left ventricular ejection fraction >35% in 254 [48%]) and in 181 healthy participants from the Intercity Digital Electrocardiogram Alliance database. During a median of 3.7 years of follow-up, 116 patients died, 52 from sudden cardiac death (SCD). In multivariate competing risk analyses, the highest QTVI quartile was associated with cardiovascular death (subhazard ratio, 1.67 [95% CI, 1.14-2.47]; P=0.009) and, in particular, with non-SCD (subhazard ratio, 2.91 [1.69-5.01]; P<0.001). Elevated QTVI separated 97.5% of healthy individuals from subjects at risk for cardiovascular (subhazard ratio, 1.57 [1.04-2.35]; P=0.031) and non-SCD in multivariate competing risk model (subhazard ratio, 2.58 [1.13-3.78]; P=0.001). No interaction between QTVI and left ventricular ejection fraction was found. QTVI predicted neither noncardiac death (P=0.546) nor SCD (P=0.945). Decreased heart rate variability rather than increased QT variability was the reason for increased QTVI in the present study. CONCLUSIONS: Increased QTVI because of depressed heart rate variability predicts cardiovascular mortality and non-SCD but neither SCD nor extracardiac mortality in heart failure across the continuum of left ventricular dysfunction. Abnormally augmented QTVI separates 97.5% of healthy individuals from heart failurepatients at risk.
Authors: Esther Pueyo; Alberto Corrias; László Virág; Norbert Jost; Tamás Szél; András Varró; Norbert Szentandrássy; Péter P Nánási; Kevin Burrage; Blanca Rodríguez Journal: Biophys J Date: 2011-12-20 Impact factor: 4.033
Authors: R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: Mark C Haigney; Wojciech Zareba; Javed M Nasir; Scott McNitt; Douglas McAdams; Philip J Gentlesk; Robert E Goldstein; Arthur J Moss Journal: Heart Rhythm Date: 2008-11-06 Impact factor: 6.343
Authors: Iwona Cygankiewicz; Wojciech Zareba; Rafael Vazquez; Antoni Bayes-Genis; Domingo Pascual; Carlos Macaya; Jesus Almendral; Miquel Fiol; Alfredo Bardaji; Jose R Gonzalez-Juanatey; Vicente Nieto; Mariano Valdes; Juan Cinca; Antoni Bayes de Luna Journal: Am J Cardiol Date: 2009-04-01 Impact factor: 2.778
Authors: Kenneth Bilchick; Matti Viitasalo; Lasse Oikarinen; Barry Fetics; Gordon Tomaselli; Heikki Swan; Päivi J Laitinen; Heikki Väänänen; Kimmo Kontula; Ronald D Berger Journal: Am J Cardiol Date: 2004-11-15 Impact factor: 2.778
Authors: Axel Bauer; Petra Barthel; Raphael Schneider; Kurt Ulm; Alexander Müller; Anke Joeinig; Raphael Stich; Antti Kiviniemi; Katerina Hnatkova; Heikki Huikuri; Albert Schömig; Marek Malik; Georg Schmidt Journal: Eur Heart J Date: 2008-12-23 Impact factor: 29.983
Authors: Larisa G Tereshchenko; Jonathan W Waks; Muammar Kabir; Elyar Ghafoori; Alexei Shvilkin; Mark E Josephson Journal: Comput Biol Med Date: 2015-03-19 Impact factor: 4.589
Authors: Natalia DeMaria; Ahmed Selmi; Samuel Kashtan; Xiaojuan Xia; Matthew Wang; Wojciech Zareba; Jean-Philippe Couderc; David S Auerbach Journal: Auton Neurosci Date: 2020-09-06 Impact factor: 3.145
Authors: Amir S Heravi; Lacey H Etzkorn; Jacek K Urbanek; Ciprian M Crainiceanu; Naresh M Punjabi; Hiroshi Ashikaga; Todd T Brown; Matthew J Budoff; Gypsyamber D'Souza; Jared W Magnani; Frank J Palella; Ronald D Berger; Katherine C Wu; Wendy S Post Journal: Circulation Date: 2019-11-11 Impact factor: 29.690